Related references
Note: Only part of the references are listed.A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine
Edward E. Walsh et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults
Allison August et al.
OPEN FORUM INFECTIOUS DISEASES (2022)
Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus
Avik Banerjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
UCSF ChimeraX: Structure visualization for researchers, educators, and developers
Eric F. Pettersen et al.
PROTEIN SCIENCE (2021)
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Raffael Nachbagauer et al.
NATURE MEDICINE (2021)
Repeated Dose Toxicity Study and Developmental and Reproductive Toxicology Studies of a Respiratory Syncytial Virus Candidate Vaccine in Rabbits and Rats
Alan H. Stokes et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2021)
The respiratory syncytial virus (RSV) prefusion F-protein functional antibody repertoire in adult healthy donors
Emanuele Andreano et al.
EMBO MOLECULAR MEDICINE (2021)
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial
Tracy J. Ruckwardt et al.
LANCET RESPIRATORY MEDICINE (2021)
Structure, Immunogenicity, and Conformation-Dependent Receptor Binding of the Postfusion Human Metapneumovirus F Protein
Jiachen Huang et al.
JOURNAL OF VIROLOGY (2021)
Interprotomer disulfide-stabilized variants of the human metapneumovirus fusion glycoprotein induce high titer-neutralizing responses
Guillaume B. E. Stewart-Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Evaluation of pre- and post-fusion Human metapneumovirus F proteins as subunit vaccine candidates in mice
Martin Pilaev et al.
VACCINE (2020)
De novo protein design enables the precise induction of RSV-neutralizing antibodies
Fabian Sesterhenn et al.
SCIENCE (2020)
A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain
Kurt A. Swanson et al.
SCIENCE IMMUNOLOGY (2020)
Antibody recognition of the Pneumovirus fusion protein trimer interface
Jiachen Huang et al.
PLOS PATHOGENS (2020)
High-Yield Expression and Purification of Recombinant Influenza Virus Proteins from Stably-Transfected Mammalian Cell Lines
Jeffrey W. Ecker et al.
VACCINES (2020)
Respiratory syncytial virus entry and how to block it
Michael B. Battles et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen
Fabian Sesterhenn et al.
PLOS BIOLOGY (2019)
Transient opening of trimeric prefusion RSV F proteins
Morgan S. A. Gilman et al.
NATURE COMMUNICATIONS (2019)
A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus In Vivo
Yael Bar-Peled et al.
JOURNAL OF VIROLOGY (2019)
Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes
Xiao Xiao et al.
MABS (2019)
Identification of T helper (Th)1-and Th2-associated antigens of Cryptococcus neoformans in a murine model of pulmonary infection
Carolina Firacative et al.
SCIENTIFIC REPORTS (2018)
Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins
Jarrod J. Mousa et al.
PLOS PATHOGENS (2018)
Chimeric Pneumoviridae fusion proteins as immunogens to induce cross-neutralizing antibody responses
Eduardo Olmedillas et al.
EMBO MOLECULAR MEDICINE (2018)
A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant
Joanne M. Langley et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
Ting Shi et al.
LANCET (2017)
Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein
Michael B. Battles et al.
NATURE COMMUNICATIONS (2017)
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
Louis Fries et al.
IMMUNITY & AGEING (2017)
A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein
Jarrod J. Mousa et al.
NATURE MICROBIOLOGY (2017)
Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus
Xiaolin Wen et al.
NATURE MICROBIOLOGY (2017)
Taxonomy of the order Mononegavirales: update 2016
Claudio L. Afonso et al.
ARCHIVES OF VIROLOGY (2016)
A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV
Xiaolin Wen et al.
PLOS ONE (2016)
Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus
April M. Killikelly et al.
SCIENTIFIC REPORTS (2016)
Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation
Vicente Mas et al.
PLOS PATHOGENS (2016)
A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice
Raffael Nachbagauer et al.
NPJ VACCINES (2016)
Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus
Jeffrey C. Boyington et al.
PLOS ONE (2016)
Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors
Morgan S. A. Gilman et al.
SCIENCE IMMUNOLOGY (2016)
Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera
Joan O. Ngwuta et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein
Bert Schepens et al.
EMBO MOLECULAR MEDICINE (2014)
Human metapneumovirus: review of an important respiratory pathogen
Swagatika Panda et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness
Ann R. Falsey et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Proof of principle for epitope-focused vaccine design
Bruno E. Correia et al.
NATURE (2014)
Activation of paramyxovirus membrane fusion and virus entry
Theodore S. Jardetzky et al.
CURRENT OPINION IN VIROLOGY (2014)
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
Davide Corti et al.
NATURE (2013)
Burden of Human Metapneumovirus Infection in Young Children
Kathryn M. Edwards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
Jason S. McLellan et al.
SCIENCE (2013)
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
Jason S. McLellan et al.
SCIENCE (2013)
Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site
Xiaolin Wen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F
Jason S. McLellan et al.
JOURNAL OF VIROLOGY (2010)
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Harish Nair et al.
LANCET (2010)
The Burden of Respiratory Syncytial Virus Infection in Young Children
Caroline Breese Hall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2
Yuta Shirogane et al.
JOURNAL OF VIROLOGY (2008)
Human metapneumovirus small hydrophobic protein inhibits NF-κB transcriptional activity
Xiaoyong Bao et al.
JOURNAL OF VIROLOGY (2008)
Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection
Rik L. de Swart et al.
VACCINE (2007)
A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo
John V. Williams et al.
JOURNAL OF VIROLOGY (2007)
Human metapneumovirus:: Enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged
Kevin C. Yim et al.
VACCINE (2007)
Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract
Herren Wu et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Function of small hydrophobic proteins of paramyxovirus
RL Wilson et al.
JOURNAL OF VIROLOGY (2006)
Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness
MS Lo et al.
JOURNAL OF VIROLOGY (2005)
Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: Effects on RNA synthesis, attenuation, and immunogenicity
UJ Buchholz et al.
JOURNAL OF VIROLOGY (2005)
Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-κB, and proinflammatory cytokines
KM Spann et al.
JOURNAL OF VIROLOGY (2005)
Respiratory syncytial virus infection in elderly and high-risk adults
AR Falsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene
WD Zhang et al.
NATURE MEDICINE (2005)
Association of matrix protein of respiratory syncytial virus with the host cell membrane of infected cells
A Marty et al.
ARCHIVES OF VIROLOGY (2004)
Innate immune response in Th1- and Th2-dominant mouse strains
H Watanabe et al.
SHOCK (2004)
A newly discovered human pneumovirus isolated from young children with respiratory tract disease
BG van den Hoogen et al.
NATURE MEDICINE (2001)
Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo
H Jin et al.
VIROLOGY (2000)
Share Paper
